Implementation of Digital Health Technology in Clinical Trials

This document is a comment published in Nature Medicine that discusses the implementation of digital health technology in clinical trials, specifically focusing on the 6R framework developed by AstraZeneca. The objective of this framework is to enhance patient experience and streamline clinical trial processes by integrating digital solutions. The text outlines the challenges faced by traditional site-based clinical trial models, including patient burden due to in-person visits. It describes how digital solutions, such as remote patient monitoring and digital biomarkers, can improve efficiency and data collection. The document also presents qualitative research conducted with patients and caregivers to understand their experiences and identify opportunities for improvement. It details specific trials, such as DAPA-MI and CRESCENDO, highlighting the benefits of reduced clinic visits, improved patient compliance, and cost reductions. Overall, the implementation of digital health technologies is portrayed as a means to optimize clinical trial design and delivery, ultimately enhancing patient access to investigational drugs.